0001127602-24-007618.txt : 20240229
0001127602-24-007618.hdr.sgml : 20240229
20240229162856
ACCESSION NUMBER: 0001127602-24-007618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Granowitz Craig B
CENTRAL INDEX KEY: 0001876655
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 24704183
MAIL ADDRESS:
STREET 1: 58 CHESTNUT STREET
STREET 2: UNIT #3
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-28
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001876655
Granowitz Craig B
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
THE WOODLANDS
TX
77381
1
SVP, Chief Medical Officer
0
Common Stock
2024-02-28
4
M
0
27916
A
43101
D
Common Stock
2024-02-28
4
M
0
35790
A
78891
D
Common Stock
2024-02-28
4
F
0
31265
2.62
D
47626
D
Restricted Stock Units
2024-02-28
4
M
0
27916
D
Common Stock
27916
27917
D
Restricted Stock Units
2024-02-28
4
M
0
35790
D
Common Stock
35790
71580
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
/s/ Craig B. Granowitz, M.D., Ph.D.
2024-02-29